Google Sister-Company Verily, Which Partnered With Pfizer in 2019, is Carrying Out Pfizer-Funded Study On 'Long-Term Safety' of Pfizer CV Shot | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

Google Sister-Company Verily, Which Partnered With Pfizer in 2019, is Carrying Out Pfizer-Funded Study On 'Long-Term Safety' of Pfizer CV Shot

"Verily, the health and life sciences company under Google parent-company Alphabet, is moving into the clinical trials space," CNBC reported in May 2019.

"The company announced Tuesday strategic alliances with the pharmaceutical companies Novartis, Sanofi, Otsuka and Pfizer to help it move more deeply into the medical studies market," CNBC continued. "The goals for Verily, and its pharma partners, are to reach patients in new ways, make it easier to enroll and participate in trials, and aggregate data across a variety of sources, including the electronic medical record or health-tracking wearable devices."

"The deals are part of Verily's Project Baseline," BioSpace reported at the time. "The Baseline Platform was developed to engage more patients and clinicians in research, speed up studies, and allow for the collection of higher quality data."

"Google has notoriously stated that its mission is, 'To organize the world's information and make it universally accessible and useful,'" BioSpace reported. "[Verily] appears to be focused on organizing the world's health and medical information."

According to Verily's website, they're currently working with Pfizer to assess the "long-term safety" of Pfizer's mRNA covid shot.

The study is "funded by Pfizer."

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA